Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
Increased methionine One of the nutrients used in lipotropic injections is methionine, which has several benefits
I lost 10 lbs., in three weeks by eating fruit for breakfast, 4 oz of meat, a bowl of veggies for lunch, and 4 oz of fish and veggies for dinner
FDA as a Category 2 bulk substance (503A/503B compounding lists) Both BPC-157 and TB-500 included on the World Anti-Doping Agency (WADA) Prohibited List under Peptide Hormones, Growth Factors, Related Substances, and Mimetics Supplied strictly as a Research Use Only (RUO) material PPE required: nitrile gloves, lab coat, protective eyewear
Remove the needle from the bottle